We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Deep Learning Powered AI Algorithms Improve Skin Cancer Diagnostic Accuracy

By LabMedica International staff writers
Posted on 16 Apr 2024
Print article
Image: AI can improve the accuracy of skin cancer diagnoses (Photo courtesy of 123RF)
Image: AI can improve the accuracy of skin cancer diagnoses (Photo courtesy of 123RF)

Artificial intelligence (AI) algorithms are increasingly being utilized in various clinical settings, such as dermatology. These algorithms are developed by training a computer with hundreds of thousands or millions of images of various skin conditions, each labeled with details like the diagnosis and patient outcomes. Through a process known as deep learning, the computer learns to identify patterns in the images that are indicative of specific skin diseases, including cancers. Once sufficiently trained, the algorithm can suggest potential diagnoses based on new images of a patient’s skin. However, these algorithms do not operate in isolation; they are used under the supervision of clinicians who evaluate the patient, make their own diagnostic assessments, and decide whether to follow the algorithm's recommendations.

Now, a new study led by researchers at Stanford Medicine (Stanford, CA, USA) has found that AI algorithms, which utilize deep learning, can enhance the accuracy of diagnosing skin cancers. This benefit extends to dermatologists, though the improvement is more pronounced for non-dermatologists. The study analyzed 12 research papers that documented over 67,000 evaluations of possible skin cancers by various medical practitioners, both with and without AI assistance. Findings indicated that healthcare practitioners without AI support accurately diagnosed approximately 75% of actual skin cancer cases and correctly identified about 81.5% of non-cancerous conditions that resembled cancer. The performance of healthcare practitioners improved when they used AI to assist with diagnoses. Their sensitivity increased to about 81.1% and their specificity to 86.1%.

Although these improvements might appear modest, they are crucial for correctly diagnosing patients who are either mistakenly told they do not have cancer when they do, or incorrectly informed they have cancer when they do not. The analysis further revealed that medical students, nurse practitioners, and primary care physicians gained the most from AI assistance, with average improvements of approximately 13 points in sensitivity and 11 points in specificity. While dermatologists and dermatology residents already showed higher overall accuracy, their diagnostic performance also saw gains in sensitivity and specificity with AI assistance. The researchers are now looking to further explore the potential and challenges of integrating AI tools into healthcare, particularly focusing on how physicians' and patients' perceptions and attitudes towards AI could affect its adoption.

“Previous studies have focused on how AI performs when compared with physicians,” said postdoctoral scholar Jiyeong Kim, PhD. “Our study compared physicians working without AI assistance with physicians using AI when diagnosing skin cancers.”

Related Links:
Stanford Medicine

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Testosterone Assay
Testosterone ELISA (REF 21-02)
New
Electroporation System
Gibco CTS Xenon

Print article

Channels

Molecular Diagnostics

view channel
Image: Three newly identified protein biomarkers have the potential to improve diagnostic tools for colorectal cancer (Photo courtesy of Adobe Stock)

New Protein Biomarkers to Improve Diagnostic Tools for Colorectal Cancer

Colorectal cancer is a leading cause of cancer-related deaths globally, and its incidence is expected to rise in the coming decades. This cancer begins when abnormal cells grow uncontrollably in the large... Read more

Microbiology

view channel
Image: The CRISPR-TB Blood Test provides accurate, rapid, and cost-effective diagnosis (Photo courtesy of 123RF)

CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening

Tuberculosis (TB) continues to be a leading cause of global mortality, with 10.6 million new cases and 1.6 million deaths annually. Diagnosing TB remains difficult, with smear microscopy offering only... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.